Cite
HARVARD Citation
Pizzuti, L. et al. (n.d.). Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor‐positive, advanced breast cancer: A real‐world experience. Journal of cellular physiology. 234 (6), pp. 7708-7717. [Online].